Acetaminophen Dosing in Obese Adolescents
The Pharmacokinetics of Intravenous Acetaminophen and Its Metabolites in Obese Children and Adolescents
Sponsor: Children's National Research Institute
Suspended
financial
Listed as NCT03192566, this PHASE3 trial focuses on Obesity, Childhood and remains suspended. Sponsored by Children's National Research Institute, it has been updated 10 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Suspended PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Suspended PHASE3
Status: Recruiting → Suspended
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE3
-
Mar 2023 — Jul 2024 [monthly]
Recruiting PHASE3
-
May 2021 — Mar 2023 [monthly]
Recruiting PHASE3
▶ Show 5 earlier versions
-
Jan 2021 — May 2021 [monthly]
Recruiting PHASE3
-
Mar 2020 — Jan 2021 [monthly]
Recruiting PHASE3
Status: Unknown Status → Recruiting
-
Jul 2019 — Mar 2020 [monthly]
Unknown Status PHASE3
Status: Recruiting → Unknown Status
-
Jun 2018 — Jul 2019 [monthly]
Recruiting PHASE3
-
Aug 2017 — Jun 2018 [monthly]
Recruiting PHASE3
First recorded
Aug 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Children's National Research Institute
For direct contact, visit the study record on ClinicalTrials.gov .